Performance. Defined.

InVitria Blog | Cell Culture and Biotech Manufacturing Insights

Recombinant Albumin for Stabilization of Live-Attenuated Viral Vaccines

Read More

Stabilizing Virus with Albumin to Improve Yield

Read More

Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Read More

Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media

Read More

Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture

Read More

Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media

Read More

Universal Vaccine Against Seasonal Influenza Steps Closer to Reality with the Results of FluGen Phase 2 Clinical Trial

Read More

Expansion of T Cells without Serum in Chemically Defined Media

Read More

ECI Conference 2019: The Latest Innovations and Trends in Cell & Gene Therapy

Read More

Phacilitate 2019 and World Stem Cell Summit

Read More

Join InVitria at ECI 2019

Read More

Join InVitria at Phacilitate 2019

Read More

Happy Holidays from the InVitria Team!

Read More

BIO Europe 2018: From Lab Innovations to Commercial Realities

Read More

WEBINAR: The Cell Culture Revolution: Commercializing Therapeutic Cell Systems

Read More

InVitria Expands Operations to Anschutz Medical Campus in the Denver Metro Area

Read More

BIO 2018: The Emergence of Gene & Cell Therapy

Read More

InVitria at the American Association of Immunologists 2018 Conference

Read More

Transferrin: An Iron Transport Protein - Recombinant Human Transferrin in Cell Culture Media

Read More

InVitria's Top Insights from ISCT 2018 - Montreal

Read More

3 Takeaways from the World Vaccine Congress 2018

Read More

Subscribe to our Blog:

Follow InVitria: